Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07FGK
|
||||
Former ID |
DIB009774
|
||||
Drug Name |
SAR-3419
|
||||
Synonyms |
HuB4-DM4; DM4-conjugated anti-CD19 monoclonal (cancer), sanofi-aventis/ImmunoGen
|
||||
Drug Type |
Antibody
|
||||
Indication | Non-hodgkin's lymphoma [ICD10:C85] | Phase 2 | [532514] | ||
Company |
ImmunoGen Inc
|
||||
Formula |
C43H63ClN4O11S2
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | B-lymphocyte antigen CD19 | Target Info | [532514] | ||
NetPath Pathway | IL-7 Signaling Pathway | ||||
PANTHER Pathway | B cell activation | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.